GLP-1 medications help break down fats in the body, which can lead to fat loss
July 18, 2025: Chinese Obesity Drug Outperforms Zepbound in Helping Patients Lose Weight, Trials Show A new obesity drug, HRS9531, made by the Chinese company Hengrui Pharma may help patients lose more weight than when on Zepbound
Semaglutide: Single-Receptor Action Semaglutide is a GLP-1 receptor agonist
Here's The Run-Down Semaglutide is a once a week subcutaneous injection that mimics the natural hormones found in our bodies that help control blood sugar levels, slow the digestive system, and tell us were full
despite a 20-hour fasting time for solids and 8-hour fasting time for liquids, the patient had significant gastric content regurgitation, although it did not evolve to bronchoaspiration